Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.67 |
| ▸ | ESR1 | P03372 | 4/20 | 0.56 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | G6PD | P11413 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 2/20 | 0.37 |
| ▸ | MAOB | P27338 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.35 |
| ▸ | RELA | Q04206 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL739399 | 1.00 | TDP1 (0.67) | TDP1CYP3A4ESR1ESR2ALDH1A1 | |
| SCHEMBL3757571 | 0.88 | CYP2A6 (0.57) | TDP1CYP3A4ESR1ESR2ALDH1A1 | |
| SCHEMBL1301471 | 0.85 | TDP1 (0.92) | TDP1CYP3A4ESR1ESR2ALDH1A1 | |
| SCHEMBL16094788 | 0.85 | TDP1 (0.92) | TDP1CYP3A4ESR1ESR2ALDH1A1 | |
| Bromide SCHEMBL11573188 | 0.82 | TDP1 (0.86) | TDP1CYP3A4ESR1ESR2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL2018015 | 0.82 | TDP1 (0.86) | TDP1CYP3A4ESR1ESR2ALDH1A1 | |
| SCHEMBL101 | 0.82 | TDP1 (1.00) | TDP1CYP3A4ESR1ESR2ALDH1A1 | |
| SCHEMBL2085135 | 0.82 | TDP1 (1.00) | TDP1CYP3A4ESR1ESR2ALDH1A1 | |
| Benzene SCHEMBL6890099 | 0.82 | TDP1 (1.00) | TDP1CYP3A4ESR1ESR2ALDH1A1 | |
| SCHEMBL5028587 | 0.82 | TDP1 (1.00) | TDP1CYP3A4ESR1ESR2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117683065-B | Phosphine ligand containing silicon-hydrogen group, preparation method and application thereof | 华东师范大学 | 2026-05-19 | — | — | CN | disclosed |
| CN-117683065-A | Phosphine ligand containing silicon-hydrogen group, preparation method and application thereof | 华东师范大学 | 2024-03-12 | — | — | CN | disclosed |
| EP-2860782-B1 | Semiconducting material comprising a phosphine oxide matrix and metal salt | NOVALED GMBH (DE) | 2019-04-17 | — | — | EP | disclosed |
| EP-1675930-B1 | NEW MATERIALS FOR ELECTROLUMINESCENCE AND THE UTILIZATION THEREOF | MERCK PATENT GMBH (DE) | 2018-05-30 | — | — | EP | disclosed |
| EP-1675930-B1 | NEW MATERIALS FOR ELECTROLUMINESCENCE AND THE UTILIZATION THEREOF | MERCK PATENT GMBH (DE) | 2018-05-30 | — | — | EP | disclosed |
| US-20180026206-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-01-25 | — | — | US | disclosed |
| EP-2366752-B1 | NEW MATERIALS FOR ELECTROLUMINESCENCE AND USE OF SAME | MERCK PATENT GMBH (DE) | 2016-07-20 | — | — | EP | disclosed |
| EP-2366752-B1 | NEW MATERIALS FOR ELECTROLUMINESCENCE AND USE OF SAME | MERCK PATENT GMBH (DE) | 2016-07-20 | — | — | EP | disclosed |
| US-8173276-B2 | Materials for electroluminescence and the utilization thereof | MERCK PATENT GMBH (DE) | 2012-05-08 | — | — | US | disclosed |
| US-8173276-B2 | Materials for electroluminescence and the utilization thereof | MERCK PATENT GMBH (DE) | 2012-05-08 | — | — | US | disclosed |
| US-20100102305-A1 | MATERIALS FOR ELECTROLUMINESCENCE AND THE UTILIZATION THEREOF | MERCK PATENT GMBH (DE) | 2010-04-29 | — | — | US | disclosed |
| US-7659540-B2 | Materials for electroluminescence and the utilization thereof | MERCK PATENT GMBH (DE) | 2010-02-09 | — | — | US | disclosed |
| US-7659540-B2 | Materials for electroluminescence and the utilization thereof | MERCK PATENT GMBH (DE) | 2010-02-09 | — | — | US | disclosed |
| US-7659540-B2 | Materials for electroluminescence and the utilization thereof | MERCK PATENT GMBH (DE) | 2010-02-09 | — | — | US | disclosed |
| US-20070080343-A1 | New materials for electroluminescence and the utilization thereof | MERCK PATENT GMBH (DE) | 2007-04-12 | — | — | US | disclosed |
| US-20070080343-A1 | New materials for electroluminescence and the utilization thereof | MERCK PATENT GMBH (DE) | 2007-04-12 | — | — | US | disclosed |
| US-20070080343-A1 | New materials for electroluminescence and the utilization thereof | MERCK PATENT GMBH (DE) | 2007-04-12 | — | — | US | disclosed |
| EP-1675930-A1 | NEW MATERIALS FOR ELECTROLUMINESCENCE AND THE UTILIZATION THEREOF | MERCK PATENT GmbH (DE) | 2006-07-05 | — | — | EP | disclosed |
| WO-2005040302-A1 | NEW MATERIALS FOR ELECTROLUMINESCENCE AND THE UTILIZATION THEREOF | MERCK PATENT GMBH (DE) | 2005-05-06 | — | — | WO | disclosed |
| US-4257973-A | USING ORGANOPHOSPHORUS-PALLADIUM HALIDE COORDINATION CATALYST | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180026206-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CYP1A1, CYP1B1 | TDP1 2502/4885CYP3A4 8/4885ESR1 41/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.